The compounds showed subnanomolar or low nanomolar 未 opioid receptor binding affinity. Depending upon the substituents on the diazatricyclodecane ring, these compounds displayed varying selectivity for 未 opioid receptor over 渭 and 魏 receptors.
Amongst the novel compounds, boldFont">1Aa showed the more interesting biological profile, with higher 未 affinity and selectivity compared to SNC-80. The 未 receptor agonist profile and antinociceptive activity of boldFont">1Aa were confirmed using ex-vivo (isolated mouse vas deferens) and in聽vivo (tail flick) assays.